作者：
Vadhan-Raj,S. [1]
;
VonMoos,R. [2]
;
Fallowfield,L.J. [3]
;
Patrick,D.L. [4]
;
Goldwasser,F. [5]
;
Cleeland,C.S. [6]
;
Henry,D.H. [7]
;
Novello,S. [8]
;
Hungria,V. [9]
;
Qian,Y. [10]
;
Feng,A. [11]
;
Yeh,H. [12]
;
Chung,K.
作者单位：
Department of Hematology, Irmandade da Santa Casa de Misericordia de S?o Paulo, S?o Paulo, Brazil
[1]
Clinical Development, Amgen Inc., Thousand Oaks, CA, United States
[2]
Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson
[3]
Global Biostatistical Sciences, Amgen Inc., Thousand Oaks, CA, United States
[4]
Division of Cancer Medicine, Department of Sarcoma Medical Oncology and Lymphoma/Myeloma, Section
[5]
Department of Medical Oncology, Kantonsspital Graubünden, Chur, Switzerland
[6]
Department of Health Services, School of Public Health, University of Washington, Seattle, WA
[7]
Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy
[8]
Department of Hematology-Oncology, Joan Karnell Cancer Center, Pennsylvania Hospital, Philadelphia
[9]
Global Health Economics, Amgen Inc., Thousand Oaks, CA, United States
[10]
Department of Medical Oncology, Paris Descartes University, AP-HP, Paris, France
[11]
Sussex Health Outcomes Research Education in Cancer (SHORE-C), University of Sussex, Brighton
[12]
发布时间
2013-11-20
换一批
